<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000082'>Impaired renal function</z:hpo> has been recognised as an independent <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factor</z:e> in the general population and in patients with established <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this issue of Diabetologia, Drury et al. examined the association of two markers of renal function with cardiovascular outcome in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>They found that both estimated glomerular filtration rate (eGFR) and <z:mp ids='MP_0002871'>albuminuria</z:mp> were independent predictors, but that their incremental contribution to cardiovascular risk was modest compared with that of other risk factors </plain></SENT>
<SENT sid="3" pm="."><plain>Both eGFR and <z:mp ids='MP_0002871'>albuminuria</z:mp> appear to integrate information from other risk factors and may be more suitable than population-based risk scores for risk prediction in individuals, but further research is required to examine whether reduced eGFR and <z:mp ids='MP_0002871'>albuminuria</z:mp> mainly represent generalised vascular damage or if <z:hpo ids='HP_0000082'>impaired renal function</z:hpo> directly affects vascular structure and function in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>